Literature DB >> 22110190

MSC(TRAIL)-mediated HepG2 cell death in direct and indirect co-cultures.

Xu-Yong Sun1, Jiang Nong, Ke Qin, Hong Lu, Mani R Moniri, Long-Jun Dai, Garth L Warnock.   

Abstract

BACKGROUND: Mesenchymal stem cells (MSCs) have attracted great interest in cancer therapy since the discovery of their tumor tropism. This study was performed to investigate the effects of TNF-related apoptosis-inducing ligand (TRAIL)-engineered MSCs on hepatocellular carcinoma (HCC) cells (HepG2) under different culture conditions.
MATERIALS AND METHODS: MSCs engineered with non-secreting TRAIL (MSC(TRAIL-GFP)) (GFP, green fluorescence protein) and secreting TRAIL (MSC(stTRAIL)) were used for the direct co-cultures, and conditioned media (CM) from corresponding cultures were applied to HepG2 as indirect co-cultures. Immunoblotting, ELISA and FACS analysis were used to detect the expression of TRAIL and TRAIL receptors. Cell death was assessed using live/dead assay.
RESULTS: Death receptor (DR) 5 was identified on the HepG2 cells. The expression of TRAIL was confirmed in the cell lysates (MSC(TRAIL-GFP) >MSC(stTRAIL)) and the conditioned media (MSC(stTRAIL) >MSC(TRAIL-GFP)). Higher cell death was observed in high MSC/HepG2 ratio co-cultures. HepG2 cell death was proportionally related to CM from MSC(TRAIL-GFP) and MSC(stTRAIL).
CONCLUSION: MSCs exhibit intrinsic inhibition of HepG2 which is potentiated by TRAIL-transfection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22110190

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  16 in total

1.  Dynamic assessment of cell viability, proliferation and migration using real time cell analyzer system (RTCA).

Authors:  Mani Roshan Moniri; Ada Young; Kelsey Reinheimer; Jarrett Rayat; Long-Jun Dai; Garth L Warnock
Journal:  Cytotechnology       Date:  2014-01-19       Impact factor: 2.058

2.  ShRNA-mediated knock-down of CXCR7 increases TRAIL-sensitivity in MCF-7 breast cancer cells.

Authors:  Weiran Gao; Xifan Mei; Jikun Wang; Xianglin Zhang; Yajiang Yuan
Journal:  Tumour Biol       Date:  2015-04-20

Review 3.  The challenge of pancreatic cancer therapy and novel treatment strategy using engineered mesenchymal stem cells.

Authors:  M R Moniri; L-J Dai; G L Warnock
Journal:  Cancer Gene Ther       Date:  2014-01-03       Impact factor: 5.987

Review 4.  Stem Cell Therapy for Hepatocellular Carcinoma: Future Perspectives.

Authors:  Hoda Elkhenany; Ahmed Shekshek; Mohamed Abdel-Daim; Nagwa El-Badri
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

5.  Adipose‑derived mesenchymal stem cell‑facilitated TRAIL expression in melanoma treatment in vitro.

Authors:  Hai Xia Jing; De Jian Duan; Hui Zhou; Qing Mei Hu; Tie Chi Lei
Journal:  Mol Med Rep       Date:  2016-05-13       Impact factor: 2.952

Review 6.  Mesenchymal stem cells as professional actors in gastrointestinal cancer therapy: From Naïve to genetically modified.

Authors:  Mehrdad Nasrollahzadeh Sabet; Masood Movahedi Asl; Mahtab Kazemi Esfeh; Navid Nasrabadi; Maryam Shakarami; Behrang Alani; Asma Alimolaie; Sara Azhdari; Ebrahim Cheraghi
Journal:  Iran J Basic Med Sci       Date:  2021-05       Impact factor: 2.699

7.  Cancer cell-oriented migration of mesenchymal stem cells engineered with an anticancer gene (PTEN): an imaging demonstration.

Authors:  Zhuo-Shun Yang; Xiang-Jun Tang; Xing-Rong Guo; Dan-Dan Zou; Xu-Yong Sun; Jing-Bo Feng; Jie Luo; Long-Jun Dai; Garth L Warnock
Journal:  Onco Targets Ther       Date:  2014-03-17       Impact factor: 4.147

8.  HSP70/CD80 DNA vaccine inhibits airway remodeling by regulating the transcription factors T-bet and GATA-3 in a murine model of chronic asthma.

Authors:  Li Yan; Shi Xiao-Ling; Cheng Zheng-Yan; Li Guo-Ping; Zhong Sen; Chen Zhuang
Journal:  Arch Med Sci       Date:  2013-02-10       Impact factor: 3.318

9.  PTEN-mRNA engineered mesenchymal stem cell-mediated cytotoxic effects on U251 glioma cells.

Authors:  Xing Rong Guo; Qin Yong Hu; Ya Hong Yuan; Xiang Jun Tang; Zhuo Shun Yang; Dan Dan Zou; Liu Jiao Bian; Long Jun Dai; Dong Sheng Li
Journal:  Oncol Lett       Date:  2016-03-01       Impact factor: 2.967

Review 10.  Therapeutic potential of CAR-T cell-derived exosomes: a cell-free modality for targeted cancer therapy.

Authors:  Xiang-Jun Tang; Xu-Yong Sun; Kuan-Ming Huang; Li Zhang; Zhuo-Shun Yang; Dan-Dan Zou; Bin Wang; Garth L Warnock; Long-Jun Dai; Jie Luo
Journal:  Oncotarget       Date:  2015-12-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.